Health
Moderna (MRNA) Starts Late Stage Trial For mRNA Bird Flu Vaccine - Yahoo Finance

What the report says
Moderna (NasdaqGS:MRNA) has advanced its mRNA-based bird flu vaccine into a late-stage clinical trial, the first of its kind in pandemic influenza. The study...
Loading debate for this article…
Other publishers covering this story
No additional verified coverage is currently clustered with this report.

Lango Seeks Japanese Investment in Agriculture, Industry and Social ServicesNile Post
Medicine shortages undermining village health teamsThe Observer
Depression: Walking Through the Three Corners of Life Toward HealingNile Post
Ebola: Uganda Reinstates Traveller Locator FormsNile Post
Atwine Warns Border Officers Over Ebola Screening Lapses at MpondweNile Post